FindMyRecallSubscribe
Class I: serious health riskTerminated

Fresenius Kabi Fluorouracil Injection Recall

Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, R…

Fresenius Kabi USA, LLC · Melrose Park, IL

Risk level
Class I
Reported by FDA
Jul 24, 2019
Recall ID
D-1489-2019
Check your lot numberHow we source this data

Summary

Fresenius Kabi recalled Fluorouracil Injection starting Jun 28, 2019. The FDA classified it as Class I (serious health risk) and published enforcement report D-1489-2019 on Jul 24, 2019. Reason: Presence of Particulate Matter; glass particulates. Status: Terminated.

Why it was recalled

Presence of Particulate Matter; glass particulates

Product description

Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, Rx Only, Mfd. by: Fresenius Kabi, Lake Zurich, IL 60047. 63323-117-61 [Fresenius Kabi brand] and NDC 63323-117-69 [NOVAPLUS brand]

Lot numbers, UPCs & expiration codes

Lot 6120420 NDC 63323-117-61, Product Code 101761 and Lot 6120341 NDC 63323-117-69, Product Code NP101761

Where it was sold

Nationwide USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1489-2019
Classification
Class I
Status
Terminated
Recall initiated
Jun 28, 2019
FDA report date
Jul 24, 2019
Quantity
14,016 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Fresenius Kabi USA, LLC

Original FDA data

Every field from FDA enforcement report D-1489-2019, exactly as published.

Show all FDA fields
City
Melrose Park
State
IL
Status
Terminated
Country
United States
Event ID
83234
Address
2045 Cornell Ave
Code information
Lot 6120420 NDC 63323-117-61, Product Code 101761 and Lot 6120341 NDC 63323-117-69, Product Code NP101761
Postal code
60160-1002
Report date
Jul 24, 2019
Product type
Drugs
Recall number
D-1489-2019
Classification
Class I
Recalling firm
Fresenius Kabi USA, LLC
Product quantity
14,016 vials
Termination date
Sep 20, 2022
Reason for recall
Presence of Particulate Matter; glass particulates
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, Rx Only, Mfd. by: Fresenius Kabi, Lake Zurich, IL 60047. 63323-117-61 [Fresenius Kabi brand] and NDC 63323-117-69 [NOVAPLUS brand]
Distribution pattern
Nationwide USA and Puerto Rico
Recall initiation date
Jun 28, 2019
Initial firm notification
Letter
Center classification date
Jul 17, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1489-2019, published Jul 24, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls